pfizer thursday strength dollar helped depress income percent fourth quarter despite percent increase sales three months ended pharmaceutical company income million cents share million cents share earlier fourth-quarter sales billion billion dollar strength against foreign currencies increased marketing expenses products continued research spending contributed percent decline income though sales increased percent pfizer although these investment expenses again sales momentum products increasing chairman edmund pratt statement pratt extended release version pfizer procardia prescription angina hypertension tallied million sales three months market company expects regulatory approval another angina hypertension norvasc which currently sells britain ireland dollar strength reduced sales percentage points turned would modest growth profits decline company strong dollar makes products expensive therefore attractive overseas income million share million share full-year sales billion billion dollar risen value sales would three percentage points higher profit decline would pfizer company sales pharmaceuticals increased percent latest while sales hospital products percent consumer products sales percent specialty chemicals sales gained percent sales animal health products percent
